74 related articles for article (PubMed ID: 1925936)
1. [The radiation-sensitizing effect of isometronidazole following its intravesical application in bladder carcinoma. A clinical phase-II study].
Kob D; Lilienthal A; Bauhardt H; Merkle K; Schröder E; Schröder E; Hentschel M
Strahlenther Onkol; 1991 Sep; 167(9):530-3. PubMed ID: 1925936
[TBL] [Abstract][Full Text] [Related]
2. [Dynamic fractionation of the radiation dosage combined with the local use of metronidazole in bladder cancer].
Pereslegin IA; Vinogradskiĭ AG; Mufazalov FF
Med Radiol (Mosk); 1989 Dec; 34(12):45-9. PubMed ID: 2601593
[TBL] [Abstract][Full Text] [Related]
3. [The radiation therapy of bladder cancer in a regimen of nontraditional fractionation with local radiomodification by metronidazole].
Pereslegin IA; Mufazalov FF
Med Radiol (Mosk); 1991; 36(12):26-8. PubMed ID: 1749327
[TBL] [Abstract][Full Text] [Related]
4. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.
Schreiber A; Krause M; Zips D; Dörfler A; Richter K; Vettermann S; Petersen C; Beuthien-Baumann B; Thümmler D; Baumann M
Strahlenther Onkol; 2004 Jun; 180(6):375-82. PubMed ID: 15175873
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
Gogna NK; Matthews JH; Turner SL; Mameghan H; Duchesne GM; Spry N; Berry MP; Keller J; Tripcony L;
Radiother Oncol; 2006 Oct; 81(1):9-17. PubMed ID: 17011058
[TBL] [Abstract][Full Text] [Related]
6. [The radiation sensitizing activity of metronidazole and iso-metronidazole (1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole)].
Proskurjakov SJ; Smoryzanova OA; Rjabcenko NI; Dedenkov AN
Radiobiol Radiother (Berl); 1990; 31(6):531-6. PubMed ID: 2101458
[TBL] [Abstract][Full Text] [Related]
7. [Instillation chemotherapy with peplomycin in superficial bladder cancer: clinical study on the effects of the direct antitumor activity and of the prophylaxis of recurrence].
Sonoda T; Osafune M; Matsuda M; Usami M
Hinyokika Kiyo; 1988 Mar; 34(3):574-81. PubMed ID: 2455442
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
9. [Radiosensitizing and toxic action of metronidazole and isometronidazole (1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole) on the cells of Ehrlich ascites cancer and hemoblastosis La in vitro].
Proskuriakov SIa; Smoryzanova OA; Dedenkov AN; Riabchenko NI
Radiobiologiia; 1986; 26(6):766-70. PubMed ID: 3809411
[TBL] [Abstract][Full Text] [Related]
10. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
[TBL] [Abstract][Full Text] [Related]
11. Improving and predicting radiosensitivity in muscle invasive bladder cancer.
Colquhoun AJ; Jones GD; Moneef MA; Bowman KJ; Kockelbergh RC; Symonds RP; Steward WP; Mellon JK
J Urol; 2003 Jun; 169(6):1983-92. PubMed ID: 12771703
[TBL] [Abstract][Full Text] [Related]
12. Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer: mature results of a Phase II nonrandomized study.
Hoskin P; Rojas A; Saunders M
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1425-31. PubMed ID: 19036531
[TBL] [Abstract][Full Text] [Related]
13. [Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer].
Flamm J; Kühnel W; Dona S
Urologe A; 1989 Mar; 28(2):99-102. PubMed ID: 2655259
[TBL] [Abstract][Full Text] [Related]
14. [Intravesical chemotherapy of superficial bladder tumors].
Matsumura Y
Gan To Kagaku Ryoho; 1989 Feb; 16(2):193-8. PubMed ID: 2645832
[TBL] [Abstract][Full Text] [Related]
15. [Effect of the combined action of metronidazole and cycloheximide on protein synthesis and tumor regression following irradiation].
Ermekova SA; Esel'baeva GO; Efimov ML
Radiobiologiia; 1983; 23(5):676-8. PubMed ID: 6689078
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of chemoradiotherapy for T1G3 bladder cancer.
Inoue M; Ishioka J; Fukuda H; Kageyama Y; Saito Y; Higashi Y
Int J Urol; 2008 Aug; 15(8):747-50. PubMed ID: 18786198
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies on the radiosensitizing action of 4-nitroimidazole and metronidazole (author's transl)].
Magdon E; Schröder E
Arch Geschwulstforsch; 1981; 51(3):225-30. PubMed ID: 7271431
[TBL] [Abstract][Full Text] [Related]
18. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder.
Poortmans PM; Richaud P; Collette L; Ho Goey S; Pierart M; Van Der Hulst M; Bolla M;
Acta Oncol; 2008; 47(5):937-40. PubMed ID: 18568488
[TBL] [Abstract][Full Text] [Related]
19. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
[TBL] [Abstract][Full Text] [Related]
20. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
